Art

J-GLOBAL ID：201802213355103827   Reference number：18A1012438

Efficacy and safety of ombitasvir/paritaprevir/ritonavir combination therapy for genotype 1b chronic hepatitis C patients complicated with chronic kidney disease

慢性腎臓病を合併した遺伝子型1b慢性C型肝炎患者に対するオムビタスビル/パリタプレビル/リトナビル併用療法の有効性と安全性

Author (20)： Arai Taeang (Department of Internal Medicine, Division of Gastroenterology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan) ,  Atsukawa Masanori (Department of Internal Medicine, Division of Gastroenterology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan) ,  Atsukawa Masanori (Department of Internal Medicine, Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan) ,  Tsubota Akihito (Core Research Facilities for Basic Science, The Jikei University School of Medicine, Tokyo, Japan) ,  Ikegami Tadashi (Department of Internal Medicine, Division of Hepatology and Gastroenterology, Tokyo Medical University, Ibaraki Medical Center, Ibaraki, Japan) ,  Shimada Noritomo (Department of Internal Medicine, Division of Gastroenterology and Hepatology, Otakanomori Hospital, Kashiwa, Japan) ,  Kato Keizo (Department of Internal Medicine, Division of Gastroenterology and Hepatology, Shinmatsudo Central General Hospital, Matsudo, Japan) ,  Abe Hiroshi (Department of Internal Medicine, Division of Gastroenterology and Hepatology, Shinmatsudo Central General Hospital, Matsudo, Japan) ,  Okubo Tomomi (Department of Internal Medicine, Division of Gastroenterology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan) ,  Itokawa Norio (Department of Internal Medicine, Division of Gastroenterology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan) ,  Kondo Chisa (Department of Internal Medicine, Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan) ,  Mikami Shigeru (Department of Internal Medicine, Division of Gastroenterology, Kikkoman General Hospital, Noda, Japan) ,  Asano Toru (Department of Internal Medicine, Division of Gastroenterology and Hepatology, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan) ,  Chuganji Yoshimichi (Department of Internal Medicine, Division of Gastroenterology and Hepatology, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan) ,  Matsuzaki Yasushi (Department of Internal Medicine, Division of Hepatology and Gastroenterology, Tokyo Medical University, Ibaraki Medical Center, Ibaraki, Japan) ,  Toyoda Hidenori (Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan) ,  Kumada Takashi (Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan) ,  Iio Etsuko (Department of Virology and Liver Unit, Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan) ,  Tanaka Yasuhito (Department of Virology and Liver Unit, Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan) ,  Iwakiri Katsuhiko (Department of Internal Medicine, Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan)
Material： Hepatology Research  (Hepatol Res)
Volume： 48  Issue： 7  Page： 549-555  Publication year： Jun. 2018 
JST Material Number： W1284A  ISSN： 1386-6346  Document type： Article
Article type： 原著論文  Country of issue： Australia (AUS)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： eGFR ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1012438&from=J-GLOBAL&jstjournalNo=W1284A") }}

Author keywords (7)： chronic hepatitis C ,  chronic kidney disease ,  direct-acting antiviral ,  genotype 1 ,  ombitasvir ,  paritaprevir ,  ritonavir

JST classification (2)： Treatment for infectious diseases,parasitic diseases.  (GD01030D) ,  Drug therapy(=pharmacotherapy)for digestive system diseases  (GH05020G)

Substance index (1)： Ombitasvir/Paritaprevir/Ritonavir

Terms in the title (11)： 慢性腎臓病 ,  合併 ,  遺伝子型1b ,  慢性C型肝炎 ,  患者 ,  オムビタスビル ,  パリタプレビル ,  リトナビル ,  併用療法 ,  有効性 ,  安全性